Found: 17
Select item for more details and to access through your institution.
A Phase II Study of XELOX and Cetuximab as First-Line Therapy in Patients With KRAS Wild Type Metastatic Colorectal Cancer (FLEET2 Study).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Laparoscopic reduced port surgery for schwannoma of the sigmoid colon: A case report.
- Published in:
- Asian Journal of Endoscopic Surgery, 2014, v. 7, n. 3, p. 260, doi. 10.1111/ases.12102
- By:
- Publication type:
- Article
FcγR and EGFR Polymorphisms as Predictive Markers of Cetuximab Efficacy in Metastatic Colorectal Cancer.
- Published in:
- Molecular Diagnosis & Therapy, 2014, v. 18, n. 5, p. 541, doi. 10.1007/s40291-014-0103-6
- By:
- Publication type:
- Article
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin-based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trials.
- Published in:
- Oncology Letters, 2019, v. 18, n. 5, p. 4555, doi. 10.3892/ol.2019.10787
- By:
- Publication type:
- Article
Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study).
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 8, p. 1515, doi. 10.1007/s10147-020-01701-1
- By:
- Publication type:
- Article
Phase II study of 5-fluorouracil–leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802).
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 7, p. 1291, doi. 10.1007/s10147-020-01656-3
- By:
- Publication type:
- Article
Efficacy of celecoxib as preemptive analgesia for patients undergoing laparoscopic inguinal hernia repair: a randomized trial.
- Published in:
- Surgery Today, 2021, v. 51, n. 7, p. 1118, doi. 10.1007/s00595-020-02199-w
- By:
- Publication type:
- Article
Disagreement between patient‐ and physician‐reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial
- Published in:
- Cancer Medicine, 2020, v. 9, n. 24, p. 9419, doi. 10.1002/cam4.3564
- By:
- Publication type:
- Article
Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 5, p. 1779, doi. 10.1002/cam4.2826
- By:
- Publication type:
- Article
A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trial.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 9, p. 4217, doi. 10.1002/cam4.1623
- By:
- Publication type:
- Article
Retrospective analysis of bevacizumab-induced hypertension and clinical outcome in patients with colorectal cancer and lung cancer.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 7, p. 1381, doi. 10.1002/cam4.701
- By:
- Publication type:
- Article
A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial.
- Published in:
- Drug Design, Development & Therapy, 2015, v. 9, n. 2015, p. 6067, doi. 10.2147/DDDT.S94901
- By:
- Publication type:
- Article
Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study).
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Importance of Evaluation of DNA Amplificability in KRAS Mutation Testing with Dideoxy Sequencing using Formalin-fixed and Paraffin-embedded Colorectal Cancer Tissues.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 2, p. 165, doi. 10.1093/jjco/hyq173
- By:
- Publication type:
- Article
Timing of resection for synchronous liver metastases from colorectal cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article